Patient engagement and experience were coming into focus as part of the overall transformation of healthcare, but the advent of Covid-19 has thrust it to the forefront. Hear from patients, providers, retailers, tech disruptors and others about why patient engagement is paramount.
Numerous companies with remote-monitoring and telehealth services closed funding rounds this week. Tyto Care, which gives users the tools to conduct an at-home medical exam with their doctor, raised $50 million. On the biotech side, Aspen Neuroscience, which is developing a new treatment for Parkinson's disease, raised $70 million.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The Israeli maker of FDA-cleared medical devices announced it has expanded its partnership with Best Buy such that its connected device kit - TytoHome - is sold in the retailer's U.S. locations.
Through the integration, patients can launch TytoCare telehealth visits from Epic's MyChart app. Following the visit, clinical exam data is delivered to the Epic EHR.
TytoCare's TytoHome product will be offered online through BestBuy.com and brick-and-mortar stores in Minnesota. Availability is also coming soon to locations in California, North Dakota and South Dakota.
From a big-city healthcare system to an expert team working in pediatrics, the 2017 honorees are advancing telemedicine in diverse ways.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
From American Well's collaboration with Tyto Care to startups Medici Technologies and Remedy, telehealth approaches are continuing to evolve.